Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Intravenous Solutions Market from 2024 to 2025?

The market for intravenous solutions has demonstrated robust growth in the past few years. The market value is anticipated to rise from $14 billion in 2024 to $15.05 billion in 2025, showing a compound annual growth rate (CAGR) of 7.5%. This impressive growth trajectory in the historic timeframe can be credited to the increase in surgical operations, the burgeoning prevalence of chronic illnesses, the expansion of home healthcare services, the implementation of rigorous regulations promoting product safety, the heightened attention to patient hydration, and worldwide initiatives for emergency readiness.

What Is the Projected Market Size of the Intravenous Solutions Market?

Anticipated to experience significant growth in the coming years, the intravenous solutions market is projected to expand to a value of $20.51 billion by 2029, with a compound annual growth rate (CAGR) of 8.0%. Several factors contribute to this predicted growth trend during the forecast period, including population expansion and aging, a rise in surgical procedures, an increased occurrence of communicable diseases, advancements in telemedicine and remote patient care, an emphasis on preventative health measures, investment in global health security, and an increasing trend towards patient-centric care. In the forecast period, it is also expected that there will be an upsurge in demand for parenteral nutrition solutions, a growing preference for pre-mixed intravenous solutions, a broadening of home-based infusion therapies, the introduction of electrolyte-balanced solutions, the debut of innovative drug additives and adjuncts, and the incorporation of intelligent intravenous systems for tracking.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13465&type=smp

Who are the Major Competitors in the Intravenous Solutions Market Outlook?

Major companies operating in the intravenous solutions market report are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.

What Is Fueling Growth in the Intravenous Solutions Market?

The intravenous solutions market is anticipated to grow due to the rising incidence of cancer. Characterized by unbridled cell growth, an ability to spread, and the capacity to invade nearby tissues, cancer necessitates the use of intravenous solutions in its treatment. Intravenous solutions facilitate the delivery of chemotherapy drugs and help maintain hydration during the treatment process. For instance, as stated by WHO, a Switzerland-based intergovernmental establishment, in February 2024, that there will be a surge of over 35 million new cancer cases by 2050, indicating a 77% climb in comparison to the estimated 20 million cases in 2022. Therefore, the surging prevalence of cancer is a significant propellant for the expansion of the intravenous solutions market. Intravenous Solutions Market Driver: Growth in Intravenous Solutions Market Boosted by Surge in Surgical Procedures

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13465&type=smp

Which Intravenous Solutions Market Segments Are Growing the Fastest?

The intravenous solutions market covered in this report is segmented –

1) By Product: Total Parenteral Nutrition, Peripheral Parenteral Nutrition

2) By Nutrients: Carbohydrates, Vitamins And Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, Other Nutrients

3) By Application: Basic Intravenous (IV) Solution, Nutritional Intravenous (IV) Solution, Blood Intravenous (IV) Solution, Drug Intravenous (IV) Solution, Irrigation Intravenous (IV) Solution

4) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings

Subsegments:

1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions, Multivitamin Solutions

2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions

Which Industry Trends Are Shaping the Future of the Intravenous Solutions Market?

Leading companies in the intravenous solutions industry are creating innovative syringes like pre-filled and ready-to-use ones to create a distinct market presence. These syringes come preloaded with medication and are designed for immediate application without needing further filling or preparation. For instance, GENIXUS Corp., a healthcare company based in the US, in August 2023, introduced KinetiXTM Rocuronium Bromide Injection in 5 mL and 10 mL ready-to-use (RTA) syringes. These syringes, created from a transparent, robust polymer, mitigate the risks tied to glass syringes. They already come filled and ready for use, which saves time and minimizes medication mistakes. Rocuronium bromide injection is strictly for intravenous application and carries several important features like RFID-enabled with KitCheck, the newest kit and tray organizing technology, easy-to-understand labeling, and a color-coded plunger rod for fast recognition.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report

Which Countries Are Leading the Intravenous Solutions Market?

North America was the largest region in the intravenous solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13465

This Report Delivers Insight On:

1. How big is the intravenous solutions market, and how is it changing globally?

2. Who are the major companies in the intravenous solutions market, and how are they performing?

3. What are the key opportunities and risks in the intravenous solutions market right now?

4. Which products or customer segments are growing the most in the intravenous solutions market?

5. What factors are helping or slowing down the growth of the intravenous solutions market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model